For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Cadus Technologies, Inc.

USPTO Granted Patents = 16

% Expired Patents = 56.3

Forward Citations = 83

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Joshua Trueheart (11 out of 32 patents)

Jeremy I Paul (9 out of 14 patents)

Christine A Klein (9 out of 14 patents)

4. John P Manfredi (9 out of 20 patents)

5. Dana M Fowlkes (8 out of 30 patents)

6. Andrew J Murphy (5 out of 367 patents)

7. James R Broach (5 out of 7 patents)

8. Andrew J M Murphy (4 out of 4 patents)

9. Jim Broach (3 out of 6 patents)

10. Lambertus J Oehlen (2 out of 2 patents)

11. Jun Xu (2 out of 2 patents)

12. Kirill Ostanin (1 out of 8 patents)

13. Benjamin K Benton (1 out of 1 patent)

14. Meng-Yu Wu (1 out of 1 patent)

15. Mary Cismowski (1 out of 4 patents)

16 patents: Sort by Forward Citations

1. 7611854 - Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor (2009-11-03),

2. 7416881 - Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor (2008-08-26),

3. 7361498 - Yeast cells expressing modified G proteins and methods of use therefor (2008-04-22),

4. 7319009 - Methods and compositions for identifying receptor effectors (2008-01-15),

5. 7273747 - Cell having amplified signal transduction pathway responses and uses therefor (2007-09-25),

6. 7250263 - Methods and compositions for identifying receptor effectors (2007-07-31),

7. 7235648 - Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor (2007-06-26),

8. 7223533 - Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways (2007-05-29),

9. 7122305 - Methods and compositions for identifying receptor effectors (2006-10-17),

10. 7105309 - Yeast cells engineered to produce pheromone system protein surrogates and uses therefor (2006-09-12),

11. 7090991 - System for detection of a functional interaction between a compound and a cellular signal transduction component (2006-08-15),

12. 7081360 - Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties (2006-07-25),

13. 7022513 - Cell based signal generation (2006-04-04),

14. 6864060 - Yeast cells expressing modified G proteins and methods of use therefor (2005-03-08),

15. 6555325 - System for detection of a functional interaction between a compound and a cellular signal transduction component (2003-04-29),

Cadus Technologies, Inc. is a New York-based company specializing in the development of advanced technologies for various sectors, including biotechnology and pharmaceuticals. The organization focuses on innovative solutions that enhance drug discovery and development processes, leveraging cutting-edge research to address complex challenges in the life sciences. With a commitment to scientific excellence, Cadus aims to contribute significantly to the advancement of therapeutic options and improve patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

16 Patents

#476 in New York, NY

#1,158 in New York

#19,898 in US

#37,766 in the World

New York, NY, United States of America

Cadus Technologies, Inc.

Forward Citations = 83

17 inventors:

Joshua Trueheart (11 out of 32 patents)

Jeremy I Paul (9 out of 14 patents)

Christine A Klein (9 out of 14 patents)

4. John P Manfredi (9 out of 20 patents)

5. Dana M Fowlkes (8 out of 30 patents)

Please report any incorrect information to [email protected]

Loading…